BioPharmaTrend
Latest News
All Topics
  • Artificial Intelligence
  • NeuroTech
  • Premium Content
  • Knowledge Center
Interviews
Companies
  • Company Directory
  • Sponsored Case Studies
  • Create Company Profile
More
  • About Us
  • Our Team
  • Advisory Board
  • Citations and Press Coverage
  • Partner Events Calendar
  • Advertise with Us
  • Write for Us
Subscribe
Login/Join

Portal Innovations Empowers Biotech Ventures in Chicago and Atlanta

by Illia Petrov   •   March 29, 2023  

Disclaimer: All opinions expressed by Contributors are their own and do not represent those of their employers, or BiopharmaTrend.com.
Contributors are fully responsible for assuring they own any required copyright for any content they submit to BiopharmaTrend.com. This website and its owners shall not be liable for neither information and content submitted for publication by Contributors, nor its accuracy.

   Biopharma insight   
Share:   Share in LinkedIn  Share in Bluesky  Share in Reddit  Share in Hacker News  Share in X  Share in Facebook  Send by email   |  

Portal Innovations, headquartered in Chicago, is a biotech-focused venture capital company seeking to bolster the expansion of biotech startups in up-and-coming life sciences centers like Chicago and Atlanta. John Flavin, the CEO of Portal, founded the company to cater to life sciences firms in ecosystems that lack the infrastructure and supportive community found in well-established hubs such as Boston and the Bay Area. Institutions like Northwestern, the University of Chicago, and the University of Illinois in Chicago have emphasized the recruitment of forward-thinking faculty in life sciences, resulting in an abundance of promising ideas. Portal Innovations provides specialized wet lab facilities to startups, equipping them with the vital infrastructure and support needed to thrive.

#advertisement
How BenchSci’s ASCEND Builds a Map for Biomedical Reasoning

Operating a $25 million fund at present, Portal Innovations has invested in a dozen of the 35 companies that occupy its 50,000 square feet of lab space. The recent decision by the Chan Zuckerberg Initiative to select Chicago as the location for its next CZ Biohub further emphasizes the growth of the city's life sciences landscape. Portal Innovations intends to broaden its scope by setting up a second laboratory in Atlanta, Georgia, in order to capitalize on the potential offered by the area's research institutions and burgeoning pool of talent. Through constructing the essential infrastructure and offering seed capital and know-how, Portal Innovations is determined to nurture the success of trailblazing biotechnology firms in these rising life sciences ecosystems.

 

Share:   Share in LinkedIn  Share in Bluesky  Share in Reddit  Share in Hacker News  Share in X  Share in Facebook  Send by email
#advertisement
ThermoFisher Scientific: Integrated genetic technologies for cell therapy development
#advertisement
Webinar: AI in Clinical Trials

BiopharmaTrend.com

Where Tech Meets Bio
mail  Newsletter
in  LinkedIn
x  X
gnews  Google News
rss  RSS Feed

About


  • What we do
  • Citations and Press Coverage
  • Terms of Use
  • Privacy Policy
  • Disclaimer

We Offer


  • Premium Content
  • BioTech Scout
  • Interviews
  • Partner Events
  • Case Studies

Opportunities


  • Membership
  • Advertise
  • Submit Company
  • Write for Us
  • Contact Us

© BPT Analytics LTD 2025
We use cookies to personalise content and to analyse our traffic. You consent to our cookies if you continue to use our website. Read more details in our cookies policy.